These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32351165)

  • 1. Long-term normalization of cognitive and psychopathological alterations in a juvenile Niemann-Pick type C case.
    la Concepción Fournier Del Castillo M; Barrio SC; Orduña BE; Jiménez IB; Marín LL; Extremera VC; Gutiérrez-Solana LG
    Neurodegener Dis Manag; 2020 Apr; 10(2):73-80. PubMed ID: 32351165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease Type C: an international, multicenter, retrospective chart review.
    Pineda M; Juríčková K; Karimzadeh P; Kolnikova M; Malinova V; Insua JL; Velten C; Kolb SA
    Orphanet J Rare Dis; 2019 Jan; 14(1):32. PubMed ID: 30732631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect.
    Nadjar Y; Hütter-Moncada AL; Latour P; Ayrignac X; Kaphan E; Tranchant C; Cintas P; Degardin A; Goizet C; Laurencin C; Martzolff L; Tilikete C; Anheim M; Audoin B; Deramecourt V; De Gaillarbois TD; Roze E; Lamari F; Vanier MT; Héron B
    Orphanet J Rare Dis; 2018 Oct; 13(1):175. PubMed ID: 30285904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C.
    Héron B; Valayannopoulos V; Baruteau J; Chabrol B; Ogier H; Latour P; Dobbelaere D; Eyer D; Labarthe F; Maurey H; Cuisset JM; de Villemeur TB; Sedel F; Vanier MT
    Orphanet J Rare Dis; 2012 Jun; 7():36. PubMed ID: 22676771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term therapy with miglustat and cognitive decline in the adult form of Niemann-Pick disease type C: a case report.
    Tozza S; Dubbioso R; Iodice R; Topa A; Esposito M; Ruggiero L; Spina E; De Rosa A; Saccà F; Santoro L; Manganelli F
    Neurol Sci; 2018 Jun; 39(6):1015-1019. PubMed ID: 29536386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of miglustat in Niemann-Pick C disease: a single centre experience.
    Ginocchio VM; D'Amico A; Bertini E; Ceravolo F; Dardis A; Verrigni D; Bembi B; Dionisi-Vici C; Deodato F
    Mol Genet Metab; 2013 Nov; 110(3):329-35. PubMed ID: 23973268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann-Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report.
    Cuisset JM; Sukno S; Trauffler A; Latour P; Dobbelaere D; Michaud L; Vallée L
    J Med Case Rep; 2016 Sep; 10(1):241. PubMed ID: 27599728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of cortical excitability and its modulation by Miglustat in Niemann-Pick disease type C.
    Hassan SS; Trenado C; Elben S; Schnitzler A; Groiss SJ
    J Clin Neurosci; 2018 Jan; 47():214-217. PubMed ID: 29074317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete recovery from psychosis upon miglustat treatment in a juvenile Niemann-Pick C patient.
    Szakszon K; Szegedi I; Magyar A; Oláh E; Andrejkovics M; Balla P; Lengyel A; Berényi E; Balogh I
    Eur J Paediatr Neurol; 2014 Jan; 18(1):75-8. PubMed ID: 24119781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: a case series.
    Pineda M; Perez-Poyato MS; O'Callaghan M; Vilaseca MA; Pocovi M; Domingo R; Portal LR; Pérez AV; Temudo T; Gaspar A; Peñas JJ; Roldán S; Fumero LM; de la Barca OB; Silva MT; Macías-Vidal J; Coll MJ
    Mol Genet Metab; 2010 Apr; 99(4):358-66. PubMed ID: 20056559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adult onset Niemann-Pick type C disease and psychosis: literature review].
    Maubert A; Hanon C; Metton JP
    Encephale; 2013 Oct; 39(5):315-9. PubMed ID: 23928063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Niemann-Pick disease type C in two children with miglustat: initial responses and maintenance of effects over 1 year.
    Chien YH; Lee NC; Tsai LK; Huang AC; Peng SF; Chen SJ; Hwu WL
    J Inherit Metab Dis; 2007 Oct; 30(5):826. PubMed ID: 17603755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral symptoms as a key diagnostic sign for the early infantile form of Niemann-Pick disease type C in a Russian patient: a case report.
    Degtyareva AV; Mikhailova SV; Zakharova EY; Tumanova EL; Puchkova AA
    J Med Case Rep; 2016 Jun; 10(1):143. PubMed ID: 27250337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and biochemical biomarkers for diagnosis and therapy monitorization of Niemann-Pick type C patients.
    Hammerschmidt TG; de Oliveira Schmitt Ribas G; Saraiva-Pereira ML; Bonatto MP; Kessler RG; Souza FTS; Trapp F; Michelin-Tirelli K; Burin MG; Giugliani R; Vargas CR
    Int J Dev Neurosci; 2018 May; 66():18-23. PubMed ID: 29197565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation and discontinuation of substrate inhibitor treatment in patients with Niemann-Pick type C disease.
    Pérez-Poyato MS; Gordo MM; Marfa MP
    Gene; 2012 Sep; 506(1):207-10. PubMed ID: 22750297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early miglustat therapy in infantile Niemann-Pick disease type C.
    Di Rocco M; Dardis A; Madeo A; Barone R; Fiumara A
    Pediatr Neurol; 2012 Jul; 47(1):40-3. PubMed ID: 22704015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of a child diagnosed with Niemann-Pick disease type C with miglustat: a case report in Brazil.
    Santos ML; Raskin S; Telles DS; Löhr A; Liberalesso PB; Vieira SC; Cordeiro ML
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S357-61. PubMed ID: 18937049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study.
    Patterson MC; Mengel E; Vanier MT; Schwierin B; Muller A; Cornelisse P; Pineda M;
    Orphanet J Rare Dis; 2015 May; 10():65. PubMed ID: 26017010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niemann-Pick type C: contemporary diagnosis and treatment of a classical disorder.
    Lad M; Thomas RH; Anderson K; Griffiths TD
    Pract Neurol; 2019 Oct; 19(5):420-423. PubMed ID: 31243140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival outcomes of patients with Niemann-Pick disease type C receiving miglustat treatment: A large retrospective observational study.
    Patterson MC; Garver WS; Giugliani R; Imrie J; Jahnova H; Meaney FJ; Nadjar Y; Vanier MT; Moneuse P; Morand O; Rosenberg D; Schwierin B; Héron B
    J Inherit Metab Dis; 2020 Sep; 43(5):1060-1069. PubMed ID: 32324281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.